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Electrical stimulation of the basal ganglia  
[e.g., the same structure that demonstrates abnormal 
physiology in Parkinson’s disease (PD) patients] 
relieves many of the motor symptoms of the disease. 
The treatment involves the placement of a permanent 
electrode in the basal ganglia as well as of a brain 
pacemaker that is placed under the skin of the 
chest and provides the power needed to produce 
electrical stimulation to the electrode inside the brain 
(Figure 1). Typically, the electrode incorporates four 
contacts that can provide various types of electrical 
stimuli. Therefore, there are many ways in which a 
physician can stimulate the brain using one electrode. 
The effect of the electrical stimulation on the motor 
symptoms of PD is almost immediate. Involuntary 
hand tremors can stop at once, the patients often 
get better control of their gait, and their quality of 
life improves. Today, deep brain stimulation for PD, 
Some patients with neurological diseases (e.g., a disease that involves abnormal brain 
function) do not respond well to the available medications and must resort to alternative 
surgical therapies to manage their symptoms. Parkinson’s disease (PD), for example, 
involves damage to a specific brain area called the basal ganglia and is characterized by 
reduced levels of a substance called dopamine in the brain. These changes to the brain 
physiology are associated with motor symptoms like imbalance, tremor, and slowness of 
motion, which can be very disabling. Fortunately, medications like levodopa can partially 
return the balance of dopamine in the brain and relieve the motor symptoms of the disease, 
especially in its early stages. However, as PD progresses, the drug therapy becomes less 
and less effective, and an additional therapy is needed.
FIGURE 1 - Typical deep brain stimulation setup.
The electrode is placed in the brain and connected to a brain pacemaker 
permanently placed under the skin of the chest.
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outcomes and adverse effects in a short time and 
without the patient attendance. A custom module 
would be able to automatically compute the best 
electrical stimulation setup to maximize treatment 
effectiveness and shorten office visit time. This 
optimization would be with respect to the patient-
specific symptoms and medications. For example, 
the optimal stimulation for a patient with left hand 
tremor could be different from that of a patient with 
left leg slowness. We hope to apply this approach to 
other diseases in the near future.
and for other neurological movement disorders, is a 
routine procedure with proven benefits. Moreover, 
its applications for additional neurological and 
psychiatric disorders are under extensive investigation 
with promising results for depression, obsessive-
compulsive disorders, and epilepsy, among others.
Despite its effectiveness, the outcomes of the deep 
brain stimulation treatment may vary with time and 
among patients, and adverse effects may appear. 
Therefore, scientists and physicians put much 
effort into improving the treatment’s outcomes 
and avoiding side effects. General guidelines for 
patient selection and careful treatment directions 
were formulated for the safe treatment of PD and 
other movement disorders, based on clinical data 
gathered in the past decade. Apparently, the general 
guidelines may prohibit an effective treatment from 
PD patients and it was estimated that about one out 
of three patients that would benefit from deep brain 
stimulation are excluded if strictly following the 
guidelines. Moreover, the guidelines cannot cover 
the large variability among patients, and two patients 
with different symptoms can receive the same 
treatment, which may be less effective compared to 
a treatment that is tailored for the specific patient. 
Therefore, the focus of our research has moved to 
a patient-specific approach, where the treatment 
is tailored to the patient’s specific symptoms and 
clinical history, among other factors.
Traditionally, it was believed that electrical 
stimulation deactivates the effected target brain area. 
However, recent studies suggest that the effect of this 
treatment is more complex, with the deactivation of 
some zones and the activation of others. Our team 
computes for each patient the spread of electrical 
stimulation in the brain, estimates the neural zones 
that are activated by a specific electrical stimulation, 
and relates the activated neural zones to the actual 
PD treatment outcomes and adverse effects (see 
Figure 2). A physician would be able to test multiple 
electrical stimulation parameters (e.g., voltage, 
frequency, etc.) and get a good estimate of their 
FIGURE 2 - A model for the effect of electrical stimulation in a patient’s brain.
The red volume represents the brain volume that will become activated 
under the specific electrical stimuli that is being considered. A stimulation of 
the gray area is expected to result in the most desired outcomes. Therefore, 
the greater the overlap between the red and gray volumes, the better. In our 
illustration, the stimulation setup that activates the brain tissue inside the 
gray zone (B) is preferred to the stimulation setup that is activating brain 
tissue mostly outside the gray zone (A). Image (C) shows the many variables 
that affect the stimulation results. Imagine how hard it is to decide on the 
values that will relieve the patient’s symptoms without any guidance.
Another interesting approach is to record the patient’s 
brain activity under motor, cognitive (e.g., memory, 
language, etc.), and psychiatric activities, and to 
create a map that relates function to tested electrode 
locations. Then, the electrode is placed in such a way 
that the target area receives most of the stimulation. 
The timing of stimulation is also under study. 
Scientists suggested stimulating only when abnormal 
brain activity is present and observed some benefits 
in animal models of PD. Further studies are needed to 
better understand its full range of effects.
In summary, deep brain electrical stimulation can be 
used to relieve neurological and psychiatric diseases 
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that would otherwise remain untreated. The focus of 
our research today is on a patient-specific approach, for 
best treatment outcomes and minimal adverse effects.
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Case Western Reserve University to create the Case Neuro-
modulation Center. Dr. McIntyre is currently appointed as 
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Medicine Department of Biomedical Engineering. The fun-
damental goal of the research program is to use knowledge 
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He is an engineer; he dedicates his time and efforts for assist-
ing people with brain diseases by developing technologies 
that improve treatment outcomes and safety. He enjoys the 
incorporation of advanced algorithms and computational 
methods into practical and useful modules that improve our 
wellbeing.
Noah, 9 years old
I have been homeschooled since I was three. I like all 
types of mechanics, especially robotics. I enjoy caring for 
my chicken, playing with my friends, gymnastics, and 
debate. When I grow up, I want to be an inventor.
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